Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Bioventus Inc. (BVS) Misses Q2 EPS by 6c; Offers FY22 Guidance
August 11, 2022 7:09 AM EDTBioventus Inc. (NASDAQ: BVS) reported Q2 EPS of $0.10, $0.06 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $140.3 million versus the consensus estimate of $138.33 million.
GUIDANCE:
Bioventus Inc. sees FY2022 EPS of $0.47-$0.57, versus the consensus of $0.65.... More
